A New Dawn in Cancer Treatment: How Targeted Protein Destruction Is Making Pancreatic Tumors Vanish
Researchers have achieved complete elimination of pancreatic cancer tumors in mice using PROTAC technology to degrade the previously undruggable KRAS G12D protein. This breakthrough targets the molecular driver of 98 percent of pancreatic cancers, offering new hope for a disease with a 12 percent five-year survival rate.